Greg Freiherr, Industry Consultant
Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | March 13, 2013

Woe is PET/MR

Woe is PET/MR

PET/MR: better together or apart? Image courtesy of Siemens, provided by University of Geneva

What a difference a few decades makes. In the early-1980s radiologists couldn’t wait to get their hands on an MR scanner. Never mind the clinical value was anything but certain. The most anybody could say is that MR absolutely, positively diagnosed multiple sclerosis. Reimbursement, shmeimbursement. Lay down a couple or three million dollars. Knock down a wall. Bring that monster in. We’ll just hope it pans out.

Not so today. PET/MR has been on the market since late-2011, FDA cleared and CE marked. At the European Congress of Radiology (ECR) March 7, Prof. Heinz-Peter Schlemmer, M.D., head of the radiology department and coordinator of the imaging and radio-oncology research program at the German Cancer Research Centre in Heidelberg, Germany, asked whether PET/MR was “a marriage made in heaven or hell?” It was a rhetorical question.

Schlemmer threw advocates a bone, explaining their initial euphoria as “understandable,” then slamming them upside the head, saying PET/MR “cannot enter routine clinical practice before diagnostic accuracy, influence on therapeutic management and economic factors have been carefully considered and evidenced by clinical studies.”

Never mind that his argument doesn’t make much sense…he may be right. In today’s global economy, novel technologies are a hard sell.

By Schlemmer’s account, PET/MR is a day late and a dollar short. Coming more than a decade after PET/CT, it would appear to have missed the boat, albeit not for lack of trying. The unique challenge of cohabitating a PET ring and superconducting magnets was why the first PET/MR images took until 2006 to make. This excludes the images fused from separately performed scans, of course. And therein may be the saving grace of PET/MR.

A good case can be made for the purchase of a hybrid. It merges data from simultaneously performed MR and PET scans, yet has the potential to conduct MR separately. Vendors leveraged the two faces of PET/CT in the early days, when demand for hybrid scans was only beginning. PET/MR can deliver about the same diagnostic information as its CT counterpart. Some believe it can do even more.

Consider oncology. MR is the go-to modality when assessing cancer. Oncology applications account for 90 percent of PET/CT. And the coming wave of biomarkers, led by Eli Lilly’s Amyvid for visualizing amyloid plaques suggestive of Alzheimer’s Disease, will be focusing more and more PET attention on the brain, another strength of MR.

Schlemmer admitted as much in his cautionary tale at the ECR. MR provides superior anatomical resolution to CT, he noted, with PET providing metabolic and membrane receptor information. “Together (PET/MR) increases your sensitivity and specificity for tumor detection and characterization,” he said.

Yet Schlemmer felt compelled to warn against putting too much stock in the hybrid’s chances, saying it remains to be seen if the simultaneous acquisition of MR and PET will deliver better accuracy than “subsequent sequencing.” I have to ask…why should we care?

Schlemmer’s argument can be turned on its head. Why not gather those data simultaneously rather than separately? Sure, you have to buy the hybrid, but you can run it in MR mode, if demand for PET/MR is not available. Reimbursement shouldn’t be an issue. MR and PET are each reimbursable.

Most astonishing is that pessimism about PET/MR should come from Europe. If there is one place on earth that should be throwing its radiological arms around PET/MR, it is Europe. Concerns about X-ray dose in the United States were first voiced on the other side of the Atlantic. MR is free from ionizing radiation.

You’d think support for PET/MR would be bubbling over there.

Related Content

Greater Left Ventricular Mass Increases Risk of Heart Failure
News | Cardiac Imaging | October 21, 2019
Elevated left ventricular mass, known as left-ventricular hypertrophy, is a stronger predictor of coronary artery...
The Revolution Apex intelligent computed tomography (CT) scanner

The Revolution Apex intelligent computed tomography (CT) scanner. Image courtesy of GE Healthcare.

News | RSNA | October 18, 2019
At the 2019 annual meeting of the Radiological Society of North America (RSNA 2019), Dec. 1-6 in Chicago, GE Healthcare...
GE Healthcare and Theragnostics Partnering on PSMA PET/CT Imaging Agent
News | Prostate Cancer | October 16, 2019
GE Healthcare and Theragnostics have entered into a global commercial partnership for a new prostate-specific membrane...
Guerbet Signs Agreement With Icometrix for Exclusive Distribution of Icobrain
News | Neuro Imaging | October 16, 2019
Guerbet announced it has signed an exclusive agreement with Icometrix for the distribution in France, Italy and Brazil...
Subtle Medical Receives FDA 510(k) Clearance for AI-powered SubtleMR
Technology | Artificial Intelligence | October 16, 2019
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtleMR. SubtleMR...
Using Compressed SENSE for faster MRI scans, healthcare providers can transform their radiology workflow.

Using Compressed SENSE for faster MRI scans, healthcare providers can transform their radiology workflow.

Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | October 16, 2019
Since the introduction of magnetic resonan...
Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI

Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI

Feature | Magnetic Resonance Imaging (MRI) | October 09, 2019 | By Jeff Zagoudis
Patient Treatments With ViewRay's MRIdian Linac Begin in New England
News | Image Guided Radiation Therapy (IGRT) | October 08, 2019
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac...
Machine Learning Could Offer Faster, More Precise Cardiac MRI Scan Results
News | Magnetic Resonance Imaging (MRI) | September 25, 2019
Cardiac magnetic resonance imaging (MRI) analysis can be performed significantly faster with similar precision to...
Colorado Orthopedic Clinic Adds Canon Medical Vantage Galan 3T MRI to Frisco Clinic Location
News | Magnetic Resonance Imaging (MRI) | September 25, 2019
The Steadman Clinic has added Canon Medical Systems USA Inc.’s Vantage Galan 3T magnetic resonance (MR) system to the...